Ben Wang | Oncology | Best Researcher Award

🎓Early Academic Pursuits

Dr. Wang Ben was born in June 1983 in Qufu, China. His academic journey began with a Bachelor of Science in Chemical Engineering at Qufu Normal University in 2004. He then pursued his Master’s in Biology at Zhejiang University, focusing on the secondary metabolism of endophytic fungi from antitumor plants. His academic excellence earned him a Ph.D. in Chemistry & Biomedical Engineering from Zhejiang University in collaboration with Harvard University in 2011, under the guidance of Prof. Ruikang Tang and Prof. Ali Khademhosseini. His doctoral research focused on cellular shellization and surface engineering for single-cell modification and protection.

Dr. Wang Ben’s career has been defined by his contributions to cancer metabolism and biomedical engineering. After completing his postdoctoral work at Zhejiang University in 2013, he served as an Associate Professor and Qiushi Young Scholar until 2022, when he was promoted to Professor. His work as Dean Assistant at the Institute of Translational Medicine and Deputy Director of the Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism showcases his leadership and contributions to the academic community. He also serves as a PI at the Cancer Institute of The Second Affiliated Hospital of Zhejiang University.

Dr. Wang’s research primarily revolves around cancer metabolism, cellular engineering, and biomedical innovations. His innovative research in translational medicine seeks to bridge laboratory research with practical clinical applications. Key areas of his research include:
- Surface engineering for single-cell modification
- Metabolism-related cancer research
- Advancements in transvascular implantation devices
Dr. Wang has also played a critical role as a panel judge for the National Natural Science Foundation of China and has been actively involved in several international research collaborations, contributing to a wide range of scientific publications.

Dr. Wang’s impact extends beyond research, with significant contributions to education and mentorship. He has undertaken extensive teaching responsibilities, from undergraduate biology courses to graduate thesis guidance, impacting hundreds of students. His mentorship has produced many successful Ph.D. and master’s candidates who have gone on to establish themselves in academia and industry.As a journal reviewer for numerous prestigious scientific publications, including ACS Nano, Advanced Materials, and Biomaterials, Dr. Wang has helped shape the discourse in chemistry, biology, and biomedical engineering fields. His expertise is highly sought after by journals such as Chemical Science and Journal of Controlled Release.

Dr. Wang Ben’s research is widely recognized within the academic community, reflected in his growing number of citations. His Google Scholar profile shows a robust citation record, underscoring the influence of his research in both cancer metabolism and biomedical engineering fields.

Dr. Wang’s legacy in the field of cancer metabolism and transvascular implantation devices continues to grow. His future work promises to contribute further to cancer treatment, aiming to integrate innovative biomedical solutions into mainstream healthcare. His leadership roles and international collaborations highlight his dedication to driving forward impactful translational medical research.

Acid-base transformative HADLA micelles alleviate colitis by restoring adaptive immunity and gut microbiome
- Authors: Cheng, W.; Zhou, X.; Jin, C.; Ji, F.; Wang, B.
- Journal: Journal of Controlled Release, 2023, Volume 364, Pages 283–296.
Targeted glycan degradation potentiates cellular immunotherapy for solid tumors
- Authors: Wu, J.; Wang, X.; Huang, Y.; Zhang, J.; Wang, B.
- Journal: Proceedings of the National Academy of Sciences of the United States of America, 2023, Volume 120(38), Article e2300366120.
A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch
- Authors: Sun, Y.; He, Q.; Li, J.; Luo, H.; Luo, Y.
- Journal: Cell Death and Disease, 2023, Volume 14(7), Article 463.
Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD
- Authors: Zhang, Y.; Wu, J.; An, Q.; Wang, B.; Lin, W.
- Journal: Nano Research, 2023, Volume 16(7), Pages 9701–9714.
Chemoimmunological Cascade Cancer Therapy Using Fluorine Assembly Nanomedicine
- Authors: Zhang, Q.; Wu, P.; Wu, J.; Wang, S.; Wang, B.
- Journal: ACS Nano, 2023, Volume 17(8), Pages 7498–7510.